Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-5565 (mirogabalin) in Asian patients with diabetic peripheral neuropathic pain
jRCT2080222690Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2014
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of mirogabalin in diabetic polyneuropathy (DPN) (4 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Change from baseline in Average Daily Pain Score (ADPS) at Week 14. Started Dec 2014; status: completed.
02
Drugs
mirogabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on jRCT2080222690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222690.